Immunovant, Inc. (IMVT) Misses Q2 EPS by 2c
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.73), $0.02 worse than the analyst estimate of ($0.71).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.73), $0.02 worse than the analyst estimate of ($0.71).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.